Erste Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-53,000
| Closed | -$9.77M | – | 887 |
|
|
2021
Q2 | $9.77M | Sell |
53,000
-4,650
| -8% | -$857K | 0.19% | 135 |
|
|
2021
Q1 | $8.85M | Hold |
57,650
| – | – | 0.22% | 131 |
|
|
2020
Q4 | $8.96M | Sell |
57,650
-13,300
| -19% | -$2.07M | 0.25% | 118 |
|
|
2020
Q3 | $7.98M | Hold |
70,950
| – | – | 0.27% | 107 |
|
|
2020
Q2 | $7.89M | Hold |
70,950
| – | – | 0.32% | 97 |
|
|
2020
Q1 | $6.19M | Sell |
70,950
-9,500
| -12% | -$829K | 0.36% | 82 |
|
|
2019
Q4 | $8.73M | Buy |
80,450
+6,200
| +8% | +$673K | 0.39% | 67 |
|
|
2019
Q3 | $7.26M | Hold |
74,250
| – | – | 0.39% | 68 |
|
|
2019
Q2 | $9.36M | Buy |
74,250
+4,100
| +6% | +$517K | 0.5% | 49 |
|
|
2019
Q1 | $9.35M | Hold |
70,150
| – | – | 0.52% | 42 |
|
|
2018
Q4 | $6.88M | Buy |
+70,150
| New | +$6.88M | 0.46% | 49 |
|